2Dershwitz M,Randel G I,Rosow C E,et al.Initial clinical experience with remifentanil,a new opioid metabolized by esterases Anesth Analg,1995,81(3):619-623.
3Rognas L K,Elkjaer P.Anaesthesia in day case laparoscopic female sterilization;a comparision of two anaesthetic methods.Acta Anaesthesiol Scand,2004,48(7):899-902.
1Fletcher D, Pinaud M, Scherpereel P, et al. The efficacy of intrsvenous 0.15 versus 0.25 mg/kg intraoperative morphone for immediate postoperative analgesia after remifentanil-based anesthesia for major surgery. Anesth Analg, 2000,90: 666-671.
2Gaundmann U, Eichner UA, Wilhelm W, etal. Total intravenous anaesthesia with propofol and remifentanil in patients: a comparison with a desflurane-nitrous oxide inhalation anesthesia. Acta Anesth Scand, 1998,42:845-850.
3Glass PSA, Hardman D, Kamiyama Y,et al.Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg, 1993,77:1031-1040.
5Hogue CW, Bowdle TA, O'Leary C, et al. A multicenter evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatient surgery. Anesth Analg, 1996,83:279-285.
6Murdoch JAC, Hyde RA, Ken GNC. Target-controlled remifentanil incombination with propofol for spontaneously breathing day-case patients.Anesthesia, 1999,54:1028-1031.
7Ahonen J, Olkkola KT, Verkkala K, et al. A comparison of remifentanil and alfentanil for use with propofol in patients undergoing minimally invasive coronary artery bypass surgery. Anesth Analg,2000,90:1269-1274.
8Bowdle TA, Camporesi EM, Maysick L, et al. A multicenter evalution of remifentanil for early postoperative analgesia. Anesth Analg, 1996, 83:1292-1297.
9Bowdle TA, Ready LB, Kharasch ED, et al. Transition to post-operative epidural or patient-controlled intravenous analgesia with remifentanil and propofol for abdominal surgery. Eur J Anaesth, 1997,14: 374-379.
10Schraag S, Kenny GN, Mohl U. Patient-maintained remifentanil targetcontrolled infusion for the transition to early postoperative analgesia. Br J Anaesth, 1998,81: 365-368.
1Kawabata Y, Nakagawa A. The optimal volume of medicinal solution in the portable disposable infusion pump (SUREFUSERA) for FOLFOX6, FOLFIRI therapy of colorectal cancer patients[J]. Yakugaku Zasshi, 2010,130(4) :621 - 627.
2Kimura F, Wada M , Kudo T, et al. Case of Rett syndrome monitored with BIS and neuromuscular monitor during total intravenous anesthesia[J]. Masui,2011,60(6) :700 - 702.
3O'Brien M,Mwangi-Powell F,Adewole IF,et al.Improving access to analgesic drugs for patients with cancer in sub-saharan Africa[J].Lancet Oncol,2013,14(4):176-182.
4Takashina Y,Naito T,Mino Y,et al.Impact of CYP3A5 and ABCB1gene polymorphisms on fentanyl pharmacokinetics and clinical responsed in cancer patients undergoing conversion to a transdermal system[J].Durg Metab Pharmacokinet,2012,27(4):414-421.
